These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 6288389
21. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG). Pauwels EK, Camps JA, Blom J, Hermans J, Kelly JD, Cumming SA, Blackburn GM, Rashid A. Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848 [Abstract] [Full Text] [Related]
22. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors]. Okuyama T, Suzuki H, Nakamoto K, Suzuki S. Kaku Igaku; 1982 Dec; 19(10):1519-30. PubMed ID: 6302357 [No Abstract] [Full Text] [Related]
23. The place of the 99mTc-polyphosphonate bone scan in renal carcinoma. Clyne CA, Frank JW, Jenkins JD, Smart CJ. Br J Urol; 1983 Apr; 55(2):174-5. PubMed ID: 6220752 [Abstract] [Full Text] [Related]
26. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. Fogelman I, Pearson DW, Bessent RG, Tofe AJ, Francis MD. J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135 [Abstract] [Full Text] [Related]
27. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate. Bruwer G, Heyns CF, Allen FJ. Eur Urol; 1999 Oct; 35(3):223-7. PubMed ID: 10072624 [Abstract] [Full Text] [Related]
28. Severe systemic reaction to diphosphonate bone imaging agents: skin testing to predict allergic response and a safe alternative agent. Ramos-Gabatin A, Orzel JA, Maloney TR, Murnane JE, Borchert RD. J Nucl Med; 1986 Sep; 27(9):1432-5. PubMed ID: 3018201 [Abstract] [Full Text] [Related]
29. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication. Mele M, Conte E, Fratello A, Pasculli D, Pieralice M, D'Addabbo A. J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136 [Abstract] [Full Text] [Related]
30. [Skeletal scintigraphic findings in spinal diseases]. Moser E. Radiologe; 1989 Apr; 29(4):164-9. PubMed ID: 2498988 [Abstract] [Full Text] [Related]
32. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications. Tan KF, Chang CH. Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712 [No Abstract] [Full Text] [Related]
33. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat. Watt I, Hill P. Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174 [Abstract] [Full Text] [Related]
34. Small cell carcinoma of the lung: primary site and hepatic metastases both detected on Tc-99m-pyrophosphate bone scan. Que L, Wiseman J, Hales IB. Clin Nucl Med; 1980 Jun; 5(6):260-2. PubMed ID: 6247115 [Abstract] [Full Text] [Related]
35. Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma. Drelichman A, Decker DA, Al-Sarraf M, Vaitkevicius VK, Muz J. Cancer; 1984 Mar 01; 53(5):1061-5. PubMed ID: 6229325 [Abstract] [Full Text] [Related]
36. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP. Bergqvist L, Brismar J, Cederquist E, Darte L, Naversten Y, Palmer J. Acta Radiol Diagn (Stockh); 1984 Mar 01; 25(3):217-23. PubMed ID: 6236672 [Abstract] [Full Text] [Related]
37. Quantitative bone scan and bone metastases in prostatic cancer. Grob JC, Thiel J, Méthlin G, Wolf P, Bollack C. Urol Int; 1985 Mar 01; 40(1):45-7. PubMed ID: 3156441 [Abstract] [Full Text] [Related]
40. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios. Buell U, Kirsch CM, Kleinhans E, Jäger B. J Nucl Med; 1983 Dec 01; 24(12):1201-2. PubMed ID: 6227711 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]